
Gefitinib: A Tool for Enhancing the Endocytosis of EGFR-Targeting Therapeutic Conjugates !
Active targeting of tumor cells relies on the use of ligands capable of specifically binding to receptors that are overexpressed on their surface, such as EGFR (epidermal growth factor receptor). Among these ligands, monoclonal antibodies and aptamers are promising tools for the targeted delivery of therapeutic molecules (chemotherapy agents,…



























